TB Trials Consortium (TBTC)

CDC assesses the need for and conducts studies of new or existing drugs and regimens used in the prevention and treatment of TB, including dosage, duration, pharmacokinetics, and toxicity. Currently, most of these trials and studies are conducted by the Tuberculosis Trials Consortium (TBTC), a unique collaboration of researchers from CDC, domestic and international public health departments and academic medical centers, and selected Veterans Administration medical centers. TBTC's mission is to conduct programmatically relevant research concerning the diagnosis, clinical management, and prevention of tuberculosis infection and disease.